bpi labs semaglutide GLP-1SG – 5mg – Prime Lab Peptides GLP-1 VIAL (10MG)
Description
Trial evidence supports larger mean weight reduction on semaglutide at 68 weeks compared to phentermine at 12 weeks
Compounded semaglutide, an unbranded semaglutide medication, is not FDA approved and thus not covered by insurance
The body weight of the patients treated with semaglutide decreased in a dose dependent manner
Serious results, sunny prices
Potential trial setbacks could delay the timeline
Diaz points to studies showing that the drugs may interfere with the production and secretion of certain hormonal and metabolic factors, possibly disrupting the structural integrity and barrier function of the skin
